Bioventus Financial Overview
Bioventus's market cap is currently $595.07M. The company's EPS TTM is $0.15; its P/E ratio is 66.79; Bioventus is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $0.20. See an overview of income statement, balance sheet, and cash flow financials.
